University of Nottingham leads study on tailored IBS Treatments through Genetic insights
An international study by Professor Mauro D’Amato found that genetic variations in carbohydrate-digesting enzymes (hCAZymes) may determine how well IBS patients respond to a low-FODMAP diet. Those with defective hCAZyme genes showed significant symptom improvement, especially in diarrhoea-predominant IBS. This discovery paves the way for personalized dietary treatments based on genetic markers.
By EPN DeskUpdated








